合成および生物学的抗リウマチ薬の安全性: 2022 EULAR リコメンデーションのためのシステマティックレビュー
Ann Rheum Dis. 2022. Epub ahead of print doi: 10.1136/ard-2022-223357
Sepriano, et al. provide results of a systematic literature review (SLR) on the safety of synthetic and biological DMARDs, to inform the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Since the 2019 EULAR recommendations for the management of RA, new evidence has emerged on the safety of synthetic and biological DMARDs in RA. This systematic literature review (SLR) updates the evidence for the safety of csDMARDs, bDMARDs and tsDMARDs in patients with RA and, alongside SLRs on efficacy and glucocorticoids, informs the task force responsible for the 2022 update of the EULAR RA management recommendations.
Keywords:
